iBio
IBIO
26 hedge funds and large institutions have $270K invested in iBio in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 7 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.18% less ownership
Funds ownership: 0.34% → 0.16% (-0.18%)
7% less funds holding
Funds holding: 28 → 26 (-2)
29% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 7
61% less capital invested
Capital invested by funds: $696K → $270K (-$426K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$27.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$15.7K |
| 3 |
VF
Virtu Financial
New York
|
+$14K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.81K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$113K |
| 2 |
Bank of New York Mellon
New York
|
-$53.4K |
| 3 |
Renaissance Technologies
New York
|
-$28K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$9.7K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$8.62K |
IBIO Hedge Fund Activity: Q3 2023 in Review
26 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q3 2023, worth a combined $270K — down 61% from $696K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of IBIO and 5 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.
The largest buyer was HRT Financial, opening a new position worth an estimated $27.5K. The largest seller was Vanguard Group, cutting an estimated $113K.
- 26 institutional investors held iBio (IBIO) as of Q3 2023, down from 28 in Q2 2023.
- Funds reported $270K of iBio stock for Q3 2023, down 61% quarter-over-quarter.
- 5 funds opened new iBio positions in Q3 2023 and 7 closed out, a net change of -2 holders.
- The largest iBio buyer in Q3 2023 was HRT Financial, an estimated $27.5K added.
- The largest iBio seller in Q3 2023 was Vanguard Group, an estimated $113K sold.
Based on aggregated 13F filings for Q3 2023.